Dr Gabriela Khoury
gabrielakhoury.bsky.social
Dr Gabriela Khoury
@gabrielakhoury.bsky.social
Antiviral Immunity Theme Leader at Burnet Institute Melbourne. Exec CI PROPHECY COVID vaccine MRFF. LOC AVS2024. We study vaccine and viral immunity in vulnerable populations. Plus the impact of viruses on our health.
June 11, 2025 at 8:36 AM
Congratulations!
March 3, 2025 at 7:39 AM
We found most KTx had impaired serological responses. Predictors of poor responses included higher mycophenolate dose and low B cell counts and in dialysis elevated monocyte counts. This work is a collaboration with Bill Mulley and colleagues at Monash Health. 2/2
December 9, 2024 at 8:06 AM
What can researchers do right away? To start, non-indigenous people can up-skill with cultural sensitivity training to ensure we can create cultural safe workplaces for First Nations people. If your institution doesn't offer this campaign for access to this training #AVS12
December 5, 2024 at 12:24 AM
Very interesting to understand the different perspectives on naming viruses isolated from country and also the data governance framework considerations when taking samples from the environment too. Looking forward to hearing more from a larger discussion from Alison Imrie. #AVS12
December 5, 2024 at 12:15 AM
Both Natalie Netzlar and Trevor Lithgow emphasised that when working on country it is so important that community is involved from the start e.g. co-design and not just as 'sign off'. As Natalie nicely highlights it makes a huge difference to coming across as working 'on' vs 'with'.
December 5, 2024 at 12:05 AM
Awesome thanks for creating such a valuable resource!
December 4, 2024 at 6:04 AM